Ranjeet Singh Mashon
Overview
Explore the profile of Ranjeet Singh Mashon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mashon R, Mandrelle K, Kakkar N
Indian J Hematol Blood Transfus
. 2025 Feb;
41(1):96-101.
PMID: 39917488
Prevention of birth of thalassemia major children by identification of risk couples and prenatal diagnosis has been recommended as a realistic and cost effective method for control of thalassemia. We...
2.
Vaswani S, Mashon R, Kakkar N
Indian J Hematol Blood Transfus
. 2019 Mar;
35(1):201-202.
PMID: 30828179
No abstract available.
3.
John M, Jyani G, Jindal A, Mashon R, Mathew A, Kakkar S, et al.
Biol Blood Marrow Transplant
. 2018 Apr;
24(10):2119-2126.
PMID: 29673692
Hematopoietic stem cell transplantation (HSCT) is the only cure for thalassemia major (TM), which inflicts a significant 1-time cost. Hence, it is important to explore the cost effectiveness of HSCT...
4.
Harrison A, Mashon R, Kakkar N, Das S
Indian J Hematol Blood Transfus
. 2018 Apr;
34(2):299-303.
PMID: 29622873
Inherited hemoglobin disorders include thalassemias and structural variants like HbS, HbE, and HbD, Hb Lepore, HbD-Iran, Hb-H disease and HbQ India. HbQ India is an uncommon alpha-chain structural hemoglobin variant...
5.
Mashon R, Kakkar N
Indian J Pathol Microbiol
. 2016 May;
59(2):262-3.
PMID: 27166068
No abstract available.
6.
Patel D, Mashon R, Purohit P, Meher S, Dehury S, Marndi C, et al.
Mediterr J Hematol Infect Dis
. 2015 Sep;
7(1):e2015050.
PMID: 26401239
Although several studies have supported that sickle cell trait (HbAS) protects against falciparum malaria, the exact mechanism by which sickle gene confers protection is unclear. Further, there is no information...
7.
Patel S, Purohit P, Mashon R, Dehury S, Meher S, Sahoo S, et al.
Pediatr Blood Cancer
. 2014 Mar;
61(8):1341-6.
PMID: 24616059
Background: Although hydroxyurea is the only effective agent for the treatment of sickle cell disease, published experience with this drug is limited to treatment of homozygous sickle cell anemia and...
8.
Mashon R, Nair S, Sawant P, Colah R, Ghosh K, Das S
Indian J Hum Genet
. 2013 Dec;
19(3):352-4.
PMID: 24339552
Structural hemoglobin (Hb) variants are mainly due to point mutations in the globin genes resulting in single amino acid substitutions. Until date, about 200 alpha chain variants have been identified...
9.
Patel D, Patel M, Mashon R, Patel S, Dash P, Das B
Hemoglobin
. 2010 Nov;
34(6):604-9.
PMID: 21077771
Fetal hemoglobin (Hb F) is the most studied modifier of sickle cell disease. Coinheritance of high Hb F determinants such as δβ-thalassemia (δβ-thal) and hereditary persistence of fetal hemoglobin (HPFH)...
10.
Mashon R, Dash P, Khalkho J, Dash L, Mohanty P, Patel S, et al.
Eur J Haematol
. 2009 Jun;
83(4):383-4.
PMID: 19508686
No abstract available.